Health Care & Life Sciences » Biotechnology | Momenta Pharmaceuticals Inc.

Momenta Pharmaceuticals Inc.

Momenta Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
78.31 M
Public Float
46 M
Momenta Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.12
Market Cap
$1.2 B
Shares Outstanding
98.61 M
Public Float
96.65 M

Profile

Address
301 Binney Street
Cambridge Massachusetts 02142
United States
Employees -
Website http://www.momentapharma.com
Updated 07/08/2019
Momenta Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products. It focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune disease. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection.

Financials

View All
Created with Highcharts 5.0.14Momenta Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.108 408108 40898 60098 60083 31383 31321 00321 00388 09688 096176 061176 061201320142015201620172018050k100k150k200k
Created with Highcharts 5.0.14Momenta Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.35 46535 46552 25052 25089 65089 650109 619109 619138 882138 88275 58975 589201320142015201620172018025k50k75k100k125k150k

Craig A. Wheeler
President, Chief Executive Officer & Director
James R. Sulat
Chairman